Truvitech's mission is to accelerate the discovery of kinase therapies and to improve the quality of life for patients during treatment. Specifically, we seek to revolutionize the process of drug target identification and, consequently, how drugs are developed and combined for maximal therapeutic impact. We achieve this through the collaborative creativity of clinicians, biologists, chemists, and computer scientists. Our teams are empowered to devise unconventional solutions that overcome the shortcomings of existing technologies.